MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$4,035K
Free Cash flow
-$4,035K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Stock-based compensation
Accrued expenses
Depreciation and amortization
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other asset...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-4,138
-4,003
-2,371
-2,392
Depreciation and amortization
1
1
1
2
Amortization of right of use asset
-
-
0
0
Net gain on disposal of property and equipment
0
3
0
0
Stock-based compensation
278
318
274
113
Prepaid expenses and other assets
931
-74
-343
269
Accounts payable
641
-175
-80
281
Accrued expenses
114
-215
-246
180
Lease liability
-
-
0
0
Net cash used in operating activities
-4,035
-4,003
-2,079
-2,085
Proceeds from sale of property and equipment
0
3
0
-
Cash paid for purchase of property and equipment
0
0
0
7
Net cash provided by (used in) investing activities
0
3
0
-7
Net proceeds from the exercise of warrants
0
0
2,835
200
Net proceeds from the issuance of common stock and warrants
0
0
9,570
8,345
Cash-in-lieu of fractional shares from reverse stock split
-
-
0
-
Payments to repurchase shares withheld for payroll taxes from restricted stock issuance
-
-
0
30
Net cash provided by financing activities
0
0
12,405
2,022
Net (decrease) increase in cash and cash equivalents
-4,035
-4,000
10,326
5,323
Cash and cash equivalents at the beginning of period
17,031
21,031
10,705
5,382
Cash and cash equivalents at end of period
12,996
17,031
21,031
10,705
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash and cash...
-$4,035K
Accounts payable
$641K
(3661.11%↑ Y/Y)
Stock-based compensation
$278K
(195.74%↑ Y/Y)
Accrued expenses
$114K
(-45.45%↓ Y/Y)
Depreciation and
amortization
$1K
Net cash used in
operating activities
-$4,035K
(-5.77%↓ Y/Y)
Canceled cashflow
$1,034K
Net loss
-$4,138K
(-5.16%↓ Y/Y)
Prepaid expenses and
other assets
$931K
(464.24%↑ Y/Y)
Buy us a coffee
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)